@techcrunch.com 6 years ago
Ourotech is taking the guesswork out of cancer treatment
@techcrunch.com 9 years ago
Amid ‘Right To Try’ Debate, myTomorrows Raises €4.5M To Give Patients Access To Development-Stage Drugs
@techcrunch.com 9 years ago
Introducing The 14 Companies Participating In Disrupt London: Startup Battlefield
@techcrunch.com 9 years ago
Introducing The Disrupt SF 2014 Startup Battlefield
@techcrunch.com 9 years ago
StartX And QB3 Open A Biotech Lab In Palo Alto